Nov 10, 2023 / 02:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q2 FY '24 Post Results Conference Call of Fortis Healthcare Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Anurag Kalra, Senior Vice President, Investor Relations at Fortis Healthcare Limited. Thank you, and over to you, Mr. Kalra.
Anurag Kalra - Fortis Healthcare Limited - VP of IR
Thank you, Gordon. A very good evening, ladies and gentlemen, and thank you for joining us on our quarter 2 FY '24 call. The call is being chaired by Dr. Ashutosh Raghuvanshi, our Managing Director and CEO. With me, we have Mr. Vivek Goyal, our Chief Financial Officer, and I also have with me my colleagues from Investor Relations and M&A , Amit as well as Avinash.
Before we start the call, I would just like to state that as you're all aware, we are a listed company and our material subsidiary, Agilus Diagnostics, has filed a DRHP for a proposed IPO in September 2023. In light of the publicity restrictions imposed on Agilus and the company, which
Q2 2024 Fortis Healthcare Ltd Earnings Call Transcript
Mar 20, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers